
Artificial Heart Valve System Developer


Looking Back on the Path of Dedication, Sailing Together in the Sea of Hearts
Gathering Strength for Progress, Achieving Leapfrog Development. At the beginning of the event, Yang Xiayan, Chief Strategy Officer of NewMed, delivered an in-depth review of the past year, 2024. She stated that throughout the previous year, the people of NewMed stood together, worked collectively, explored jointly, and moved steadily forward. NewMed doubled down on "research," committing to in-depth study and breaking through technical barriers; moved towards "life," focusing on clinical needs to safeguard lives; expanded its "external" cooperation boundaries, continuously accelerating the commercialization process; advanced towards "innovation," leveraging strong self-developed capabilities to establish an extensive patent portfolio. Meanwhile, the company turned the blade inward, adhering to the strategic thought of "cost reduction and efficiency enhancement," pushing forward internal reforms and optimization, fully activating the endogenous driving force of the enterprise, and injecting a powerful engine for development.

Gather Role Model Strength, Showcase Team Spirit
Years Reflect初心, Legacy Everlasting. Looking back at 2024, all colleagues stood together through thick and thin, supporting NewMed in its steady and far-reaching progress on the fast-developing path, building momentum for the future. The company's growth relies on the contribution of high-quality talent, who, through their actions, practice NewMed’s core values and write the epic story of NewMed people's endeavors.
During the highly anticipated advanced awards ceremony, the company presented significant awards to outstanding individuals and teams. The guests in attendance cheered and celebrated the achievements of their colleagues, with the power of exemplary role models inspiring all NewMed employees to forge ahead.

Draw a New Blueprint Together, Embark on a New Journey Anew
Swipe left and right to view more
The tide of the times surges forward. Standing at a new starting point, all NewMed employees, guided by NewMed's strategic goals and development plans, will strive with a resolute and innovative attitude, seize opportunities to continuously surpass ourselves, adhere to the principles of professionalism, safety, and efficiency, and work together with top experts in China’s cardiovascular disease field to scale new heights in medicine and jointly write a new chapter in the interventional treatment of heart valves.
